为使作者了解我刊的编辑出版计划，及时地为我刊惠赐稿件，《临床肝胆病杂志》编委会确定了2022年1-12期“重点号”选题及各期执行主编：

1期  大数据与人工智能赋能肝脏外科数字诊疗新时代····················刘景丰

2期  儿童肝衰竭的诊断与治疗······························王建设

3期  肝癌精准诊疗新进展································陈磊

4期  自身免疫性肝病——识机制进展，促临床提升·····················闫惠平

5期  免疫治疗新时代下肝胆肿瘤治疗新进展························周俭

6期  肝硬化门静脉高压的进展与挑战···························陈金军

7期  非肝硬化性门静脉高压研究进展···························徐小元

8期  从基础的视角看慢性乙型肝炎治愈及在研新药临床试验评价···············鲁凤民

9期  肝硬化及其主要合并症的中西医结合治疗·······················刘平

10期  异种肝移植的发展与创新······························窦科峰

11期 不同人群抗HBV治疗的时机与药物选择·························窦晓光

12期  胰腺疾病内外科诊治································张澍田

为本刊重点号的投稿请注明“* * *重点号投稿”字样。

对于围绕重点号选题的文章，本刊将择优优先发表。欢迎广大作者踊跃投稿。

《临床肝胆病杂志》编辑部

2022年4月20日